NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, February 19th. Stockholders of record on Friday, March 1st will be paid a dividend of $0.19 per share on Monday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Thursday, February 28th. View Baxter International's Dividend History.

Baxter International declared that its board has initiated a stock repurchase plan on Tuesday, November 13th 2018, which authorizes the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 6.1% of its shares through open market purchases. Shares buyback plans are often a sign that the company's management believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) released its quarterly earnings data on Thursday, January, 31st. The medical instruments supplier reported $0.78 EPS for the quarter, topping the consensus estimate of $0.73 by $0.05. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a net margin of 14.60% and a return on equity of 19.10%. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for Baxter International.

Baxter International will be holding an earnings conference call on Thursday, April 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8448861929.

Baxter International updated its FY19 earnings guidance on Thursday, January, 31st. The company provided EPS guidance of $3.22-3.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.27. The company issued revenue guidance of ~$11.1-11.2 billion, compared to the consensus revenue estimate of $11.37 billion.Baxter International also updated its FY 2019 guidance to $3.22-3.30 EPS.

15 equities research analysts have issued 12 month target prices for Baxter International's stock. Their forecasts range from $70.00 to $85.00. On average, they expect Baxter International's stock price to reach $76.7333 in the next twelve months. This suggests that the stock has a possible downside of 2.2%. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News coverage about BAX stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baxter International earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the immediate future.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), Insulet (PODD), Penumbra (PEN), ICU Medical (ICUI), Integra Lifesciences (IART) and Novocure (NVCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include Johnson & Johnson (JNJ), Cisco Systems (CSCO), Intel (INTC), Pfizer (PFE), CA (CA), General Electric (GE), Verizon Communications (VZ), Home Depot (HD), Gilead Sciences (GILD) and Bank of America (BAC).

Baxter International's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.29%), Third Point LLC (5.26%), FMR LLC (4.52%), Northern Trust Corp (1.62%), Norges Bank (1.57%) and Geode Capital Management LLC (1.21%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, FMR LLC, Two Sigma Advisers LP, APG Asset Management N.V., Harris Associates L P, Canada Pension Plan Investment Board, BlackRock Inc. and Standard Life Aberdeen plc. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Oregon Public Employees Retirement Fund, State of Tennessee Treasury Department, California Public Employees Retirement System, Mackenzie Financial Corp, State of New Jersey Common Pension Fund D, Eaton Vance Management and Mawer Investment Management Ltd.. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $78.45.

Baxter International has a market capitalization of $40.21 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]